Connect with us
Last year, German biotechnology companies raised approximately $957 million (€860 million) in capital from venture capital and capital increases via the stock exchange. This included two...
Argenx is a biotechnological company that develops antibody-based drugs. The company is planning to become a global immunology company in 2021, as its liquid assets have...
Pharmaceutical companies have become an important part of the Spanish economy. Companies in this sector had a strong year and some were able to triple their...
2019 was another strong year for blockchain technology. The best performer is Bitcoin, which maintains a heavy dominance in the cryptocurrency market. Burger King in Venezuela...
Robot puppies have been back in vogue for a few years now. They are significantly more sophisticated than the pocket pets enjoyed by kids and adults...
The small synthetic biology company “Syngulon” develops technologies based on bacteriocins, natural molecule properties which are of interest to several industrial sectors. It has just signed...
BioNTech is a biotechnology company that is working towards revolutionary new cancer treatment methods. The company is headquartered in the upper city of Mainz and has...
In the biotechnology sector, buyouts and licensing agreements are almost always accompanied by development milestones and other milestone payments. Analysts have attempted to quantify the share...
The sale of the biotechnology group Qiagen from Hilden in North Rhine-Westphalia is off the table for the time being. After fruitless talks with interested parties,...
With the Yoyo, the Italian startup XEV plans to launch a light, inexpensive electric car that is perfect for the city by the end of 2020....